Cargando…
Cutaneous Leishmaniasis Vaccination: A Matter of Quality
There have been exhaustive efforts to develop an efficient vaccine against leishmaniasis. Factors like host and parasite genetic characteristics, virulence, epidemiological scenarios, and, mainly, diverse immune responses triggered by Leishmania species make the achievement of this aim a complex tas...
Autores principales: | De Luca, Paula Mello, Macedo, Amanda Beatriz Barreto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838622/ https://www.ncbi.nlm.nih.gov/pubmed/27148270 http://dx.doi.org/10.3389/fimmu.2016.00151 |
Ejemplares similares
-
Protective Immunity and Vaccination Against Cutaneous Leishmaniasis
por: Okwor, Ifeoma, et al.
Publicado: (2012) -
Identification of Immunodominant Antigens From a First-Generation Vaccine Against Cutaneous Leishmaniasis
por: Germanó, María José, et al.
Publicado: (2022) -
Host-Directed Therapies for Cutaneous Leishmaniasis
por: Novais, Fernanda O., et al.
Publicado: (2021) -
Vaccines for Canine Leishmaniasis
por: Palatnik-de-Sousa, Clarisa B.
Publicado: (2012) -
Opinion Article: NK Cells in Cutaneous Leishmaniasis: Protection or Damage?
por: Cavalcante, Marton Kaique de Andrade, et al.
Publicado: (2022)